STAT

NOVEMBER 13, 2023

The life expectancy of men in the U.S. is nearly six years shorter than that of women, according to new research published on Monday in JAMA Internal Medicine. At least partially as a consequence of over 1 million Covid-19 deaths, life expectancy in the U.S. has declined significantly over the past few years, falling from 78.8 years in 2019 to 77 in 2020 and 76.1 in 2022 — undoing over two decades of progress.

364

364

PharmaVoice

NOVEMBER 13, 2023

The arsenal against the world’s deadliest creature is growing and a universal vaccine is in the works.

Vaccines 290

Vaccines 290

STAT

NOVEMBER 13, 2023

A small and preliminary study published Monday seems to indicate that patients receiving the drug Paxlovid are far more likely to experience Covid rebound than those who did not take it. That conclusion runs counter to previous statements by Pfizer, which makes Paxlovid, and by researchers at the Food and Drug Administration who have argued that while it is not uncommon for people with Covid to have symptoms reemerge after they seem to have recovered, it is not clear that Paxlovid increases the

363

363

ALiEM - Pharm Pearls

NOVEMBER 13, 2023

A 57-year-old female college counselor living in the northeastern United States with no PMH presented for evaluation of rash, joint pain, and dyspnea for the past three weeks. The patient first noticed the rash on her upper back, describing it as being itchy. The rash then spread to her face, scalp, and thighs. Two weeks ago, she noticed swelling in her hands and had a gradual onset of dyspnea on exertion.

Inpatient 197

Inpatient 197

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 13, 2023

WASHINGTON – The American Medical Association called on insurance companies, employers, and government programs to cover obesity treatments even as many remain reluctant to pay for them, fearing the costs of covering the drugs at a mass scale. The large physicians’ lobbying group voted to pass a resolution at the association’s interim meeting Monday saying it will “urge all payers to ensure coverage parity for evidence-based treatment of obesity, including FDA- approv

360

360

PharmaVoice

NOVEMBER 13, 2023

What if your advisory solution was a skillful blend of innovative tech, medical communications specialists, high-touch client service, and a flexible contract?

Communication 130

Communication 130

BioPharma Dive

NOVEMBER 13, 2023

Forge Biologics operates a contract manufacturing business as well as develops its own gene therapies, which appears to have attracted the Japan-based food and biotechnology company.

109

109

STAT

NOVEMBER 13, 2023

How many radiologists does it take to build a working MRI from scratch? New York University radiologists Leeor Alon and Tobias Block wanted to find out. The two hosted 50 researchers in New York City last month, and over the course of five days, managed to build a small, low-field MRI. Alon and Block are currently fine-tuning its imaging abilities. The overarching message of the gathering: MRIs don’t need to be as expensive as they currently are.

328

328

BioPharma Dive

NOVEMBER 13, 2023

Trial results add to evidence that so-called Factor XIa inhibitors could have less bleeding risk than currently available oral anticoagulants like Xarelto.

114

114

STAT

NOVEMBER 13, 2023

PHILADELPHIA — In a sense, the annual meeting of the American Heart Association wasn’t a huge one for Eli Lilly. Its biggest news was about a very early study of a drug to lower blood levels Lp(a), a protein related to cholesterol that is mainly being watched by lipidologists and drug company analysts. But in another way, the future of Lilly, now the biggest drug company by market capitalization, hung in the balance.

322

322

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

BioPharma Dive

NOVEMBER 13, 2023

Regulatory agencies have set the framework and use cases for RWE. How can these increase the probability of success or efficiency in a pre-clinical and clinical drug development program?

Drug Development 106

Drug Development 106

STAT

NOVEMBER 13, 2023

PHILADELPHIA – Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease. The landmark Select trial presented over the weekend – which showed Wegovy significantly cut the risk of heart complications – is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space.

Diabetes 312

Diabetes Drug Development 312

The Pharmacist

NOVEMBER 13, 2023

Victoria Atkins has been appointed as the new health secretary in a Cabinet reshuffle, Downing Street has confirmed. Prime Minister Rishi Sunak has appointed the Lincolnshire MP to succeed Steve Barclay in the reshuffle of his top team today. Mr Barclay will stay in the Cabinet as environment, food and rural affairs secretary. Vicky Atkins […] The post Victoria Atkins replaces Steve Barclay as health secretary appeared first on The Pharmacist.

105

105

STAT

NOVEMBER 13, 2023

Last week those of us who work in reproductive health care  celebrated a historic victory  in Ohio: Voters overwhelmingly favored Issue 1, which enshrines a right to abortion into the state constitution and makes the six-week ban many of us feared unenforceable. As an abortion provider in Cleveland, I’m relieved that my patients’ freedom to access abortion care, miscarriage care, and contraception is protected.

287

287

The Pharmacist

NOVEMBER 13, 2023

Pharmacy minister Neil O’Brien has resigned from his post, saying that he wants to focus on constituency work and time with his family. This comes as other junior ministers, including former pharmacy minister and then minister for Health and Secondary Care Will Quince have also handed in their resignations. It follows a major cabinet shake-up, […] The post Pharmacy minister quits amid government shake-up appeared first on The Pharmacist.

103

103

STAT

NOVEMBER 13, 2023

A one-of-a-kind law in Michigan that prevents the state government and residents from suing pharmaceutical companies over injuries caused by their medicines is poised to be pared back. A bill designed to allow product liability lawsuits to be filed against drug companies passed the Michigan Senate last month and then passed the House last week. The legislation , which won overwhelming majorities in both chambers but was opposed by the Michigan Chamber of Commerce and a pharmaceutical industry tr

Pharmaceutical Companies 266

Pharmaceutical Companies Pharmaceutical Companies 266

Express Pharma

NOVEMBER 13, 2023

In the ever-evolving landscape of medical device assembly, innovation knows no boundaries. Leaders in medical device assembly are pioneering solutions with unprecedented capabilities to produce multiple product types, facilitating small-batch flexibility without compromising on productivity. This represents a significant shift towards the utilisation of machines that can adapt, acknowledged as adaptive machines, and excel in performance with dynamic changes in manufacturing processes and consume

Packaging 100

Packaging Communication 100

STAT

NOVEMBER 13, 2023

A diabetes diagnosis was not what Jason had in mind when he set out on a cross-country road trip with his family in the fall of 2021. He had been heavy since he was a kid, but he always had felt pretty healthy — until getting home to the San Francisco Bay Area, when he started to notice his body doing strange things. “It kind of came out of nowhere,” said Jason, who asked to keep his last name private.

Diabetes 254

Diabetes 254

Pharmaceutical Technology

NOVEMBER 13, 2023

As per the company, the candidate THIO, is the only direct telomere-targeting agent currently in clinical development.

111

111

STAT

NOVEMBER 13, 2023

With the election of Rep. Mike Johnson as speaker of the House, the urgent and important work of passing appropriations and vital national security legislation is now advancing. But it is also the time to address additional important issues affecting the well-being of Americans, such as one highlighted during the Covid-19 pandemic as well as recent wildfires and hurricanes: the care and support for America’s most vulnerable.

231

231

European Pharmaceutical Review

NOVEMBER 13, 2023

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for GSK’s momelotinib, recommending marketing approval. The Committee deemed it beneficial as a treatment for disease-related splenomegaly (enlarged spleen) or symptoms in adults with moderate to severe anaemia who have primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis and who are Janus kinase (JAK) inhibitor n

Adverse Reactions 87

Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies 87

STAT

NOVEMBER 13, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Lots of news on the cardiovascular front this morning: We discuss Novo Nordisk’s plans in heart disease, and Verve’s gene editing therapy for familial hypercholesterolemia. We also learn about a new initiative to try and prevent gonorrhea spread with a meningitis vaccine.

Vaccines 216

Vaccines Drug Pricing Drug Development 216

pharmaphorum

NOVEMBER 13, 2023

Where old pathways to innovative cancer care fall short, a new model emerges Mike.

127

127

STAT

NOVEMBER 13, 2023

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  The crushing weight of ambulance bills Over the summer, Precious Mae Clark (in the photo above) emailed me with a desperate plea: She was staring down the barrel of a $7,370 (I repeat, $7,370!

Hospitals 209

Hospitals 209

PharmExec

NOVEMBER 13, 2023

The growing issue of medical debt has caused stakeholders to reevaluate tactics as the cost of pharmaceutical healthcare continues to rise.

98

98

STAT

NOVEMBER 13, 2023

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online calls, meetings, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. To nudge it in a better direction, we are firing up the coffee kettle to brew another cup of stimulation.

Diabetes 204

Diabetes 204

World Pharma News

NOVEMBER 13, 2023

Artificial intelligence (AI) is on the rise. Until now, AI applications generally have "black box" character: How AI arrives at its results remains hidden. Prof. Dr. Jürgen Bajorath, a cheminformatics scientist at the University of Bonn, and his team have developed a method that reveals how certain AI applications work in pharmaceutical research.

89

89

STAT

NOVEMBER 13, 2023

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague. Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague.

182

182

Pharma Times

NOVEMBER 13, 2023

Antimicrobial resistance is considered one of the top ten global public health threats - News - PharmaTimes

Biosimilars 102

Biosimilars 102

Pharmaceutical Technology

NOVEMBER 13, 2023

The UK government has announced £267m ($326.4m) funds for developing treatments for drug and alcohol misuse.

95

95

Pharma Times

NOVEMBER 13, 2023

The trial is evaluating an investigational cancer vaccine in combination with Keytruda - News - PharmaTimes

Vaccines 100

Vaccines 100

The Pharmacist

NOVEMBER 13, 2023

Widespread prescribing by pharmacists from 2026 is likely to add a ‘judicious’ approach to medicines prescribing, chief pharmaceutical officer (CPhO) for England David Webb suggested at the Royal Pharmaceutical Society’s (RPS) Annual Conference last week. With more pharmacists becoming independent prescribers, Mr Webb suggested that the profession could play a role in reducing the overprescribing […] The post CPhO: Pharmacists bring ‘judicious approach’ to medicines prescribing appeared fi

78

78

pharmaphorum

NOVEMBER 13, 2023

ADCs shine at ESMO ’23, as pharma makes case for early immunotherapy interventions Mike.

104

104

Pharmaceutical Technology

NOVEMBER 13, 2023

At the BIO-Europe conference, experts discussed remaining challenges in AI healthcare interventions.

98

98

Outsourcing Pharma

NOVEMBER 13, 2023

A small molecule, oral targeted therapy for adults with metastatic colorectal cancer (CRC) has been approved by the US Food and Drug Administration (FDA).

98

98